Connect with us
Initial trial results for SPVN06 are expected in 2023, with first efficacy data expected in 2025. SparingVision is also developing SPVN20, a second gene therapy drug...
Three quarters through the year and the bear market continues. Third consecutive negative quarter. The bond market is suffering its worst bear market in years yet...
Markets don’t like being oversold. So, I expect we may see a bounce in the Dow Jones in the coming weeks. But, should we actually see a bounce...
According to data from Crowdfunding Buzz's observatory on real estate crowdfunding, in 2022, to date, real estate crowdfunding has raised more than €92 million, of which...
CaixaResearch promotes cutting-edge research in health and biomedicine. The "la Caixa" Foundation's call for health research supports 33 projects of excellence from universities and research centers...
Parents looking to put money aside that will help cover education expenses, consider taking out a savings plan designed for tuition fees. There are also a...
Starting a business is always a difficult undertaking, and for many of us, it can be tough to know where to even begin. If you’re looking...
In this week's TopRanked.io affiliate marketing digest, we check out the latest from Google and highlight two coming updates that provide new opportunities for affiliate marketers....
Each of the clinics that make up IVI RMA's worldwide network (more than 65 clinics) is likely to pursue one or more of the lines of...
The announcement follows last July's announcement at the Beyond event in Turin, Italy, and the official launch of Blue Energy Motors' first liquefied natural gas (LNG)-powered...